EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 110 filers reported holding EDITAS MEDICINE INC in Q2 2017. The put-call ratio across all filers is 1.04 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,437,100,000 | -20.5% | 415,000 | -13.5% | 0.98% | -12.1% |
| Q2 2019 | $11,875,200,000 | +101086.1% | 480,000 | 0.0% | 1.11% | -13.7% |
| Q1 2019 | $11,736,000 | +7.5% | 480,000 | 0.0% | 1.29% | -31.0% |
| Q4 2018 | $10,920,000 | -25.4% | 480,000 | +4.3% | 1.87% | +5.0% |
| Q3 2018 | $14,637,000 | +129.1% | 460,000 | +157.9% | 1.78% | +99.0% |
| Q2 2018 | $6,390,000 | +44.6% | 178,333 | +33.8% | 0.89% | +15.1% |
| Q1 2018 | $4,420,000 | +7.9% | 133,333 | 0.0% | 0.78% | -22.1% |
| Q4 2017 | $4,097,000 | +28.0% | 133,333 | 0.0% | 1.00% | +10.4% |
| Q3 2017 | $3,201,000 | +43.1% | 133,333 | 0.0% | 0.90% | +9.3% |
| Q2 2017 | $2,237,000 | -24.8% | 133,333 | 0.0% | 0.83% | -52.9% |
| Q1 2017 | $2,976,000 | +182.1% | 133,333 | +105.1% | 1.76% | +101.6% |
| Q4 2016 | $1,055,000 | -8.4% | 65,000 | -23.9% | 0.87% | -6.6% |
| Q3 2016 | $1,152,000 | -61.0% | 85,470 | 0.0% | 0.93% | -72.5% |
| Q1 2016 | $2,952,000 | – | 85,470 | – | 3.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |